Hangzhou Jeci Biochem Technology Co., Ltd. is strategically located in the heart of China's pharmaceutical innovation hub, Hangzhou, Zhejiang Province. As a premier China custom Macrolides manufacturer, we have carved a niche in the global market by offering a comprehensive suite of services including the R&D, custom synthesis, and international distribution of Active Pharmaceutical Ingredients (APIs) and advanced intermediates.
Our commitment extends beyond mere production; we bridge the gap between complex biochemical engineering and practical pharmaceutical applications. Our expertise spans across nutritional products, food additives, and critical pharmaceutical intermediates that form the backbone of modern medicine.
The global macrolide market is witnessing a significant transformation driven by the rising demand for efficient antimicrobial agents in both human and veterinary medicine. As bacteria evolve, the need for high-purity Macrolides like Tilmicosin and Erythromycin derivatives becomes paramount. Industries worldwide are seeking manufacturers who can provide not just raw materials, but stabilized formulations that ensure bio-availability and safety.
Our flagship product, the Tilmicosin 25% Oral Solution, is a testament to our manufacturing prowess. In the livestock industry, respiratory diseases represent a major economic threat. This GMP-certified formulation offers rapid absorption and targeted action, making it a preferred choice for large-scale farm management in South Asia and Latin America.
View Technical Specifications →Emerging trends indicate a shift towards "Green Chemistry" in macrolide production. China, being the world's largest producer, is leading this transition by implementing stricter environmental protocols and automated fermentation processes. Jeci Biochem is at the forefront of this movement, ensuring our custom manufacturing processes minimize waste while maximizing yield.
Our Macrolide derivatives and intermediates find extensive use across various high-value sectors:
Equipped with state-of-the-art batch processing units, we handle everything from pilot-scale production to large-scale industrial supply. Our manufacturing facility is optimized for the synthesis of advanced intermediates, ensuring consistency in every batch.
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
Global procurement teams often face challenges regarding regulatory compliance and supply chain stability. As an experienced exporter of Macrolides, we mitigate these risks through:
We provide comprehensive factory quality management system certification consulting and product registration services for overseas companies entering the Chinese market.
Our strong collaborative R&D team works in-depth with new drug research institutes to provide exclusive technology transfer and custom processing services.
With very good domestic sales channels and long-term relationships with global partners in India and Southeast Asia, we ensure seamless logistics and supply.
In regions like Southeast Asia, the poultry and swine industries require localized pharmaceutical support. Our Factory Supply Veterinary Drug 25% Tilmicosin Oral Solution is specifically designed for ease of administration via drinking water systems, catering to the intensive farming practices of the region. By understanding local climatic challenges and pathogen profiles, we provide customized concentrations and stability profiles that outperform standard generic offerings.
Request Localized Solution Quotation →The industry is moving towards more targeted drug delivery systems. Future macrolide developments will focus on reducing resistance through synergistic combinations and sustained-release formulas. Jeci Biochem is already investing in R&D to explore these "smart" API delivery methods, ensuring our clients remain competitive in an evolving pharmaceutical landscape.
SJ medical